|
|
Regel 4: |
Regel 4: |
| | | |
| =Addenda voor inhoudelijke gegevens= | | =Addenda voor inhoudelijke gegevens= |
− | == Overzicht van scenario's voor sturend/beschikbaarstellend systeem == | + | == Example instance== |
− | | + | <section begin=mv-example-920-1 /><section begin=patient-mv-example-920-1 /> |
− | === Scenarioset ===
| |
− | <section begin=overview-VOS- />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |999|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)</span></div>|| MBH_920_test1-AWE|| MBH_920_test1-AWE-MA|| MBH_920_test1-AWE_VV
| |
− | |}
| |
− | <section end=overview-VOS- />
| |
− | === Scenarioset 1===
| |
− | <section begin=overview-VOS-1 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</span></div>|| MBH_920_start_eind-BSC|| MBH_920_start_eind_MA-BSC|| MBH_920_start_eind_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_920_start_duur-BSC|| MBH_920_start_duur_MA-BSC|| MBH_920_start_duur_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)</span></div>|| MBH_920_start_duur2-BSC|| MBH_920_start_duur2_MA-BSC|| MBH_920_start_duur2_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.3|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)</span></div>|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC|| MBH_920_chronisch_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.4|| Maak screenshot(s) waaruit blijkt dat het extra VV gemaakt wordt/behoort bij de eerdere MA.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Extra VV onder bestaande MA</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: VV bij de bestaande MA uit scenario 1.3</span></div>|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC|| MBH_920_chronisch_VV_extraVVbestaandeMA-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.5|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_920_dosis_stuks-BSC|| MBH_920_dosis_stuks_MA-BSC|| MBH_920_dosis_stuks_VV-BSC
| |
− | |}
| |
− | <section end=overview-VOS-1 />
| |
− | === Scenarioset 2===
| |
− | <section begin=overview-VOS-2 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende instructie (MA)</span></div>|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA-VNK|| MBH_920_aanvullendeinstructie_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.2|| Maak screenshot(s) waaruit blijkt dat bij zowel de MA als VV een 'toelichting' ingevoerd kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Toelichting (MA), toelichting (VV)</span></div>|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA-VNK|| MBH_920_toelichting_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Reden van voorschrijven (MA)</span></div>|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA-VNK|| MBH_920_redenvanvoorschrijven_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.4*|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (MA) en 'aanvullende wensen' (VV) zichtbaar zijn|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV), </span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA), </span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">meerdere MBHs in één voorschriftbericht (denk aan meerdere receptregels op een recept)</span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;"><span style="color: #172b4d; font-family: -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Oxygen, Ubuntu, Fira Sans, Droid Sans, Helvetica Neue, sans-serif;">.</span></span></div>|| MBH_920_aanvullendeinformatiewensen-VNK<br>MBH_920_Toedieningsweg-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK<br>MBH_920_Toedieningsweg_MA-VNK|| MBH_920_aanvullendeinformatiewensen_VV-VNK<br>MBH_920_Toedieningsweg_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.5*|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' (MA) en 'aanvullende wensen' (VV) zichtbaar zijn|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV)</span></div>|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK|| MBH_920_aanvullendeinformatiewensen_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.6*|| Maak screenshot(s) waarop toedieningsweg keuze zichtbaar is|| <div><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA)</span></div>|| MBH_920_Toedieningsweg-VNK|| MBH_920_Toedieningsweg_MA-VNK|| MBH_920_Toedieningsweg_VV-VNK
| |
− | |}
| |
− | <section end=overview-VOS-2 />
| |
− | === Scenarioset 3===
| |
− | <section begin=overview-VOS-3 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.1|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-medicatieafspraak, met reden staken</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: stop medicatieafspraak van scenario 2.1</span></div>|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA_staken-VNK||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.2</span></div>|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA_wijzigingmetVV-VNK<br>MBH_920_toelichting_MA_techstaken-VNK|| MBH_920_toelichting_VV_extra-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.3</span></div>|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK<br>MBH_920_redenvanvoorschrijven_MA_techstaken-VNK||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.4 optioneel|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken medicatieafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking medicatieafspraak van scenario 2.4/2.5</span></div>|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK||
| |
− | |}
| |
− | <section end=overview-VOS-3 />
| |
− | === Scenarioset 4===
| |
− | <section begin=overview-VOS-4 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |4.1|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht in MA</span></div> <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht in MA</span></div>|| MBH_920_Lengte_Gewicht-MLN|| MBH_920_Lengte_Gewicht_MA_1-MLN|| MBH_920_Lengte_Gewicht_VV_1-MLN
| |
− | |}
| |
− | <section end=overview-VOS-4 />
| |
− | === Scenarioset 6===
| |
− | <section begin=overview-VOS-6 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.1 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Variabele frequentie</span></div>|| MBH_920_variabelefrequentie-JNK|| MBH_920_variabelefrequentie_MA-JNK|| MBH_920_variabelefrequentie_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.2 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Interval</span></div>|| MBH_920_interval-JNK|| MBH_920_interval_MA-JNK|| MBH_920_interval_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.3 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (1)</span></div>|| MBH_920_variabelehoeveelheid-JNK|| MBH_920_variabelehoeveelheid_MA-JNK|| MBH_920_variabelehoeveelheid_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.4 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zonder keerdosis</span></div>|| MBH_920_zonderkeerdosis-JNK|| MBH_920_zonderkeerdosis_MA-JNK|| MBH_920_zonderkeerdosis_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.5 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Bijzondere keerdosis</span></div>|| MBH_920_bijzonderekeerdosis-JNK|| MBH_920_bijzonderekeerdosis_MA-JNK|| MBH_920_bijzonderekeerdosis_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.6 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (2)</span></div>|| MBH_920_variabelehoeveelheid2-JNK|| MBH_920_variabelehoeveelheid2_MA-JNK|| MBH_920_variabelehoeveelheid2_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.7*|| Maak screenshot(s) waarop zichtbaar is dat aangegeven kan worden of het tijdstip gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen</span></div>|| MBH_920_tijdstippen-JNK|| MBH_920_tijdstippen_MA-JNK|| MBH_920_tijdstippen_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.8 optioneel|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Weekdagen</span></div>|| MBH_920_weekdagen-JNK|| MBH_920_weekdagen_MA-JNK|| MBH_920_weekdagen_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.9*|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_920_dagdeel-JNK|| MBH_920_dagdeel_MA-JNK|| MBH_920_dagdeel_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.10 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Cyclisch schema</span></div>|| MBH_920_cyclischschema-JNK|| MBH_920_cyclischschema_MA-JNK|| MBH_920_cyclischschema_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.11 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Afbouw schema en doseerduur</span></div>|| MBH_920_afbouwschema-JNK|| MBH_920_afbouwschema_MA-JNK|| MBH_920_afbouwschema_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.12 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid en maximum</span></div>|| MBH_920_variabelehoeveelheidenmaximum-JNK|| MBH_920_variabelehoeveelheidenmaximum_MA-JNK|| MBH_920_variabelehoeveelheidenmaximum_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.13 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningssnelheid</span></div>|| MBH_920_toedieningssnelheid-JNK|| MBH_920_toedieningssnelheid_MA-JNK|| MBH_920_toedieningssnelheid_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.14 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningsduur</span></div>|| MBH_920_toedieningsduur-JNK|| MBH_920_toedieningsduur_MA-JNK|| MBH_920_toedieningsduur_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zo nodig</span></div>|| MBH_920_zonodig-JNK|| MBH_920_zonodig_MA-JNK|| MBH_920_zonodig_VV-JNK
| |
− | |}
| |
− | <section end=overview-VOS-6 />
| |
− | === Scenarioset 7===
| |
− | <section begin=overview-VOS-7 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |7.1 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_920_magistraalalleingredienten-JNK|| MBH_920_magistraalalleingredienten_MA-JNK|| MBH_920_magistraalalleingredienten_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |7.2 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_920_magistraalactieveingredient-JNK|| MBH_920_magistraalactieveingredient_MA-JNK|| MBH_920_magistraalactieveingredient_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |7.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">90 miljoen nummer</span></div>|| MBH_920_magistraal90miljoennr-JNK|| MBH_920_magistraal90miljoennr_MA-JNK|| MBH_920_magistraal90miljoennr_VV-JNK
| |
− | |}
| |
− | <section end=overview-VOS-7 />
| |
− | === Scenarioset 8===
| |
− | <section begin=overview-VOS-8 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.1|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Verstrekkingsverzoek onder andermans medicatieafspraak</span></div>|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP|| MBH_920_VVandermansMA_VV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.2|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stoppen andermans medicatieafspraak</span></div>|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA2-ZTP||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.3 optioneel|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Onderbreken andermans medicatieafspraak</span></div>|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA2-ZTP||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.4|| Maak screenshot(s) na het versturen van het voorschrift waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Wijzigen andermans medicatieafspraak</span></div>|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA_techstaken-ZTP<br>MBH_920_wijzigenandermansMA_MA2-ZTP||
| |
− | |}
| |
− | <section end=overview-VOS-8 />
| |
− | === Scenarioset 8i===
| |
− | <section begin=overview-VOS-8i />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.01|| || <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.1</span></div>|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP|| MBH_920_VVandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.02|| || <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.2</span></div>|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA1-ZTP|| MBH_920_stakenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.03|| || <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.3</span></div>|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA1-ZTP|| MBH_920_onderbrekenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.04|| || <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.4</span></div>|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA1-ZTP|| MBH_920_wijzigenandermansMA_andermansVV-ZTP
| |
− | |}
| |
− | <section end=overview-VOS-8i />
| |
− | === Scenarioset 9===
| |
− | <section begin=overview-VOS-9 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.1a optioneel|| Maak screenshot(s) waarin zichtbaar is dat een logistieke verbruiksperiode ingevoerd kan worden (ingangsdatum en duur/einddatum)|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_920_logistiekeverbruiksperiode_start_eind-BSC|| MBH_920_logistiekeverbruiksperiode_start_eind_MA-BSC|| MBH_920_logistiekeverbruiksperiode_start_eind_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.1b optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_920_logistiekeverbruiksperiode_eind-BSC|| MBH_920_logistiekeverbruiksperiode_eind_MA-BSC|| MBH_920_logistiekeverbruiksperiode_eind_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.1c optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC|| MBH_920_logistiekeverbruiksperiode_duur_dagen_MA-BSC|| MBH_920_logistiekeverbruiksperiode_duur_dagen_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.2 optioneel|| Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Herhalingen</span></div>|| MBH_920_herhalingen-BSC|| MBH_920_herhalingen_MA-BSC|| MBH_920_herhalingen_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Afleverlocatie</span></div>|| MBH_920_afleverlocatie-BSC|| MBH_920_afleverlocatie_MA-BSC|| MBH_920_afleverlocatie_VV-BSC
| |
− | |}
| |
− | <section end=overview-VOS-9 />
| |
− | === Scenarioset 10===
| |
− | <section begin=overview-VOS-10 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |10.1 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">HPK geneesmiddel</span></div>|| MBH_920_HPKvoorschrijven-BSC|| MBH_920_HPKvoorschrijven_MA-BSC|| MBH_920_HPKvoorschrijven_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |10.2 optioneel|| || <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">ZI-nr geneesmiddel</span></div>|| MBH_920_ZINRvoorschrijven-BSC|| MBH_920_ZINRvoorschrijven_MA-BSC|| MBH_920_ZINRvoorschrijven_VV-BSC
| |
− | |}
| |
− | <section end=overview-VOS-10 />
| |
− | == Overzicht van scenario's voor ontvangend systeem ==
| |
− | | |
− | === Scenarioset ===
| |
− | <section begin=overview-VOO- />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |999|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)</span></div>|| MBH_920_test1-AWE|| MBH_920_test1-AWE-MA|| MBH_920_test1-AWE_VV
| |
− | |}
| |
− | <section end=overview-VOO- />
| |
− | === Scenarioset 1===
| |
− | <section begin=overview-VOO-1 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en einddatum</span></div>|| MBH_920_start_eind-BSC|| MBH_920_start_eind_MA-BSC|| MBH_920_start_eind_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.2a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)</span></div>|| MBH_920_start_duur-BSC|| MBH_920_start_duur_MA-BSC|| MBH_920_start_duur_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.2b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)</span></div>|| MBH_920_start_duur2-BSC|| MBH_920_start_duur2_MA-BSC|| MBH_920_start_duur2_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met een medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)</span></div>|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC|| MBH_920_chronisch_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Extra VV onder bestaande MA</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: VV bij de bestaande MA uit scenario 1.3</span></div>|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC|| MBH_920_chronisch_VV_extraVVbestaandeMA-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |1.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Medicatievoorschrift met eenheid 'dosis/stuks'</span></div>|| MBH_920_dosis_stuks-BSC|| MBH_920_dosis_stuks_MA-BSC|| MBH_920_dosis_stuks_VV-BSC
| |
− | |}
| |
− | <section end=overview-VOO-1 />
| |
− | === Scenarioset 2===
| |
− | <section begin=overview-VOO-2 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende instructie (MA)</span></div>|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA-VNK|| MBH_920_aanvullendeinstructie_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Toelichting (MA), toelichting (VV)</span></div>|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA-VNK|| MBH_920_toelichting_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Reden van voorschrijven (MA)</span></div>|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA-VNK|| MBH_920_redenvanvoorschrijven_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV), </span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA), </span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">meerdere MBHs in één voorschriftbericht (denk aan meerdere receptregels op een recept)</span><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;"><span style="color: #172b4d; font-family: -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Oxygen, Ubuntu, Fira Sans, Droid Sans, Helvetica Neue, sans-serif;">.</span></span></div>|| MBH_920_aanvullendeinformatiewensen-VNK<br>MBH_920_Toedieningsweg-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK<br>MBH_920_Toedieningsweg_MA-VNK|| MBH_920_aanvullendeinformatiewensen_VV-VNK<br>MBH_920_Toedieningsweg_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Aanvullende informatie (MA), aanvullende wensen (VV)</span></div>|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK|| MBH_920_aanvullendeinformatiewensen_VV-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |2.6|| <div><span style="background-color: #f9f9f9; font-family: sans-serif; font-size: 14px;">Toedieningsweg (MA)</span></div>|| MBH_920_Toedieningsweg-VNK|| MBH_920_Toedieningsweg_MA-VNK|| MBH_920_Toedieningsweg_VV-VNK
| |
− | |}
| |
− | <section end=overview-VOO-2 />
| |
− | === Scenarioset 3===
| |
− | <section begin=overview-VOO-3 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stop-medicatieafspraak, met reden staken</span><br style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;"><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9; color: #ff0000;">LET OP: stop medicatieafspraak van scenario 2.1</span></div>|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA_staken-VNK||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) met VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.2</span></div>|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA_wijzigingmetVV-VNK<br>MBH_920_toelichting_MA_techstaken-VNK|| MBH_920_toelichting_VV_extra-VNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma) zonder VV</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: wijziging medicatieafspraak van scenario 2.3</span></div>|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK<br>MBH_920_redenvanvoorschrijven_MA_techstaken-VNK||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |3.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Onderbreken medicatieafspraak</span><br style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;"><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff; color: #ff0000;">LET OP: onderbreking medicatieafspraak van scenario 2.4/2.5</span></div>|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK||
| |
− | |}
| |
− | <section end=overview-VOO-3 />
| |
− | === Scenarioset 4===
| |
− | <section begin=overview-VOO-4 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |4.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht in MA</span></div> <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Medicatievoorschrift, met lengte en gewicht in MA</span></div>|| MBH_920_Lengte_Gewicht-MLN|| MBH_920_Lengte_Gewicht_MA_1-MLN|| MBH_920_Lengte_Gewicht_VV_1-MLN
| |
− | |}
| |
− | <section end=overview-VOO-4 />
| |
− | === Scenarioset 6===
| |
− | <section begin=overview-VOO-6 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Variabele frequentie</span></div>|| MBH_920_variabelefrequentie-JNK|| MBH_920_variabelefrequentie_MA-JNK|| MBH_920_variabelefrequentie_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Interval</span></div>|| MBH_920_interval-JNK|| MBH_920_interval_MA-JNK|| MBH_920_interval_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (1)</span></div>|| MBH_920_variabelehoeveelheid-JNK|| MBH_920_variabelehoeveelheid_MA-JNK|| MBH_920_variabelehoeveelheid_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zonder keerdosis</span></div>|| MBH_920_zonderkeerdosis-JNK|| MBH_920_zonderkeerdosis_MA-JNK|| MBH_920_zonderkeerdosis_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.5|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Bijzondere keerdosis</span></div>|| MBH_920_bijzonderekeerdosis-JNK|| MBH_920_bijzonderekeerdosis_MA-JNK|| MBH_920_bijzonderekeerdosis_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.6|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid (2)</span></div>|| MBH_920_variabelehoeveelheid2-JNK|| MBH_920_variabelehoeveelheid2_MA-JNK|| MBH_920_variabelehoeveelheid2_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.7|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Tijdstippen</span></div>|| MBH_920_tijdstippen-JNK|| MBH_920_tijdstippen_MA-JNK|| MBH_920_tijdstippen_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.8|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Weekdagen</span></div>|| MBH_920_weekdagen-JNK|| MBH_920_weekdagen_MA-JNK|| MBH_920_weekdagen_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.9|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Dagdeel</span></div>|| MBH_920_dagdeel-JNK|| MBH_920_dagdeel_MA-JNK|| MBH_920_dagdeel_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.10|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Cyclisch schema</span></div>|| MBH_920_cyclischschema-JNK|| MBH_920_cyclischschema_MA-JNK|| MBH_920_cyclischschema_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.11|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Afbouw schema en doseerduur</span></div>|| MBH_920_afbouwschema-JNK|| MBH_920_afbouwschema_MA-JNK|| MBH_920_afbouwschema_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.12|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Variabele hoeveelheid en maximum</span></div>|| MBH_920_variabelehoeveelheidenmaximum-JNK|| MBH_920_variabelehoeveelheidenmaximum_MA-JNK|| MBH_920_variabelehoeveelheidenmaximum_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.13|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningssnelheid</span></div>|| MBH_920_toedieningssnelheid-JNK|| MBH_920_toedieningssnelheid_MA-JNK|| MBH_920_toedieningssnelheid_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.14|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Toedieningsduur</span></div>|| MBH_920_toedieningsduur-JNK|| MBH_920_toedieningsduur_MA-JNK|| MBH_920_toedieningsduur_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |6.15|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Zo nodig</span></div>|| MBH_920_zonodig-JNK|| MBH_920_zonodig_MA-JNK|| MBH_920_zonodig_VV-JNK
| |
− | |}
| |
− | <section end=overview-VOO-6 />
| |
− | === Scenarioset 7===
| |
− | <section begin=overview-VOO-7 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |7.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Alle ingrediënten</span></div>|| MBH_920_magistraalalleingredienten-JNK|| MBH_920_magistraalalleingredienten_MA-JNK|| MBH_920_magistraalalleingredienten_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |7.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">Actief ingrediënt</span></div>|| MBH_920_magistraalactieveingredient-JNK|| MBH_920_magistraalactieveingredient_MA-JNK|| MBH_920_magistraalactieveingredient_VV-JNK
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |7.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #ffffff;">90 miljoen nummer</span></div>|| MBH_920_magistraal90miljoennr-JNK|| MBH_920_magistraal90miljoennr_MA-JNK|| MBH_920_magistraal90miljoennr_VV-JNK
| |
− | |}
| |
− | <section end=overview-VOO-7 />
| |
− | === Scenarioset 8===
| |
− | <section begin=overview-VOO-8 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Verstrekkingsverzoek onder andermans medicatieafspraak</span></div>|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP|| MBH_920_VVandermansMA_VV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Stoppen andermans medicatieafspraak</span></div>|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA2-ZTP||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Onderbreken andermans medicatieafspraak</span></div>|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA2-ZTP||
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8.4|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Wijzigen andermans medicatieafspraak</span></div>|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA_techstaken-ZTP<br>MBH_920_wijzigenandermansMA_MA2-ZTP||
| |
− | |}
| |
− | <section end=overview-VOO-8 />
| |
− | === Scenarioset 8i===
| |
− | <section begin=overview-VOO-8i />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.01|| <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.1</span></div>|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP|| MBH_920_VVandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.02|| <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.2</span></div>|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA1-ZTP|| MBH_920_stakenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.03|| <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.3</span></div>|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA1-ZTP|| MBH_920_onderbrekenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |8i.04|| <div><span style="color: #c0c0c0; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Ontvangen van voorschrift als voorbereiding scenario 8.4</span></div>|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA1-ZTP|| MBH_920_wijzigenandermansMA_andermansVV-ZTP
| |
− | |}
| |
− | <section end=overview-VOO-8i />
| |
− | === Scenarioset 9===
| |
− | <section begin=overview-VOO-9 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.1a|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_920_logistiekeverbruiksperiode_start_eind-BSC|| MBH_920_logistiekeverbruiksperiode_start_eind_MA-BSC|| MBH_920_logistiekeverbruiksperiode_start_eind_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.1b|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_920_logistiekeverbruiksperiode_eind-BSC|| MBH_920_logistiekeverbruiksperiode_eind_MA-BSC|| MBH_920_logistiekeverbruiksperiode_eind_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.1c|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Logistieke verbruiksperiode</span></div>|| MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC|| MBH_920_logistiekeverbruiksperiode_duur_dagen_MA-BSC|| MBH_920_logistiekeverbruiksperiode_duur_dagen_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Herhalingen</span></div>|| MBH_920_herhalingen-BSC|| MBH_920_herhalingen_MA-BSC|| MBH_920_herhalingen_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |9.3|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">Afleverlocatie</span></div>|| MBH_920_afleverlocatie-BSC|| MBH_920_afleverlocatie_MA-BSC|| MBH_920_afleverlocatie_VV-BSC
| |
− | |}
| |
− | <section end=overview-VOO-9 />
| |
− | === Scenarioset 10===
| |
− | <section begin=overview-VOO-10 />
| |
− | {| class="wikitable"
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | | Scenario|| Beschrijving|| MBH id|| MA id|| VV id
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |10.1|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">HPK geneesmiddel</span></div>|| MBH_920_HPKvoorschrijven-BSC|| MBH_920_HPKvoorschrijven_MA-BSC|| MBH_920_HPKvoorschrijven_VV-BSC
| |
− | |-style="vertical-align:top;|style="background-color: white;"
| |
− | |10.2|| <div><span style="font-family: sans-serif; font-size: 14px; background-color: #f9f9f9;">ZI-nr geneesmiddel</span></div>|| MBH_920_ZINRvoorschrijven-BSC|| MBH_920_ZINRvoorschrijven_MA-BSC|| MBH_920_ZINRvoorschrijven_VV-BSC
| |
− | |}
| |
− | <section end=overview-VOO-10 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_start_eind==
| |
− | <section begin=mv-mvr-Scenarioset1-MBH_920_start_eind-1 /><section begin=patient-mv-mvr-Scenarioset1-MBH_920_start_eind-1 /> | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset1-MBH_920_start_eind-1 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_920_start_eind-1 />
| |
− | ==== Scenario 1.1 - MBH_920_start_eind-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_start_eind_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_start_eind_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 11:20 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 5 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c77655e8-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 5 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_start_eind-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_start_eind_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_start_eind_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 11:20 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7765610-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|5 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c776562a-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_start_eind_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_start_eind-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset1-MBH_920_start_eind-1 /><section end=mv-mvr-Scenarioset1-MBH_920_start_eind-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_start_duur==
| |
− | <section begin=mv-mvr-Scenarioset1-MBH_920_start_duur-2 /><section begin=patient-mv-mvr-Scenarioset1-MBH_920_start_duur-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset1-MBH_920_start_duur-2 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_920_start_duur-2 />
| |
− | ==== Scenario 1.2a - MBH_920_start_duur-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_start_duur_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 11:30 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, gedurende 3 weken''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Gebruiksduur
| |
− | |style="background-color: white;"|3 weken
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c77672bc-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, gedurende 3 weken, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_start_duur_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 11:30 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c77672e4-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|21 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c77672fe-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_start_duur_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset1-MBH_920_start_duur-2 /><section end=mv-mvr-Scenarioset1-MBH_920_start_duur-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_start_duur2==
| |
− | <section begin=mv-mvr-Scenarioset1-MBH_920_start_duur2-5 /><section begin=patient-mv-mvr-Scenarioset1-MBH_920_start_duur2-5 />
| |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
Regel 653: |
Regel 21: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Naamgebruik | | |colspan="3"|Naamgebruik |
− | |style="background-color: white;"|1 | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Geslachtsnaam | | |colspan="4"|Geslachtsnaam |
Regel 669: |
Regel 37: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Geboortedatum | | |colspan="4"|Geboortedatum |
− | |style="background-color: white;"|1964-01-08 | + | |style="background-color: white;"|8 jan 1964 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Geslacht | | |colspan="4"|Geslacht |
− | |style="background-color: white;"|2 | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient-mv-mvr-Scenarioset1-MBH_920_start_duur2-5 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_920_start_duur2-5 /> | + | |}<section end=patient-mv-example-920-1 /><section begin=mbhs-mv-example-920-1 /> |
− | ==== Scenario 1.2b - MBH_920_start_duur2-BSC==== | + | ==== Scenario 999 - MBH_920_mv_example-1==== |
| | | |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_start_duur2_MA-BSC | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_mv_example-1-MA |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="3" width="25%"| Gegevenselement | | |colspan="3" width="25%"| Gegevenselement |
Regel 684: |
Regel 52: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Identificatie | | |colspan="3"|Identificatie |
− | |style="background-color: white;"|MBH_920_start_duur2_MA-BSC | + | |style="background-color: white;"|MBH_920_mv_example-1-MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 60 dagen om 11:30 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 60 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Gebruiksduur
| |
− | |style="background-color: white;"|28 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c776745d-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur2-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_start_duur2_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur2_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 60 dagen om 11:30 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7767485-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|28 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c776749f-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_start_duur2_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_start_duur2-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset1-MBH_920_start_duur2-5 /><section end=mv-mvr-Scenarioset1-MBH_920_start_duur2-5 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_chronisch==
| |
− | <section begin=mv-mvr-Scenarioset1-MBH_920_chronisch-3 /><section begin=patient-mv-mvr-Scenarioset1-MBH_920_chronisch-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset1-MBH_920_chronisch-3 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_920_chronisch-3 />
| |
− | ==== Scenario 1.3 - MBH_920_chronisch-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_chronisch_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_chronisch_MA-BSC
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Medicatieafspraak datum tijd | | |colspan="3"|Medicatieafspraak datum tijd |
Regel 837: |
Regel 70: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Zorgverlener | | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"|uuid_c7767373-e33e-11eb-2032-020000000000 | + | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Geneesmiddel - primaire code | | |colspan="3"|Geneesmiddel - primaire code |
Regel 853: |
Regel 86: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Toedieningsweg | | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Doseerinstructie | | |colspan="2"|Doseerinstructie |
Regel 859: |
Regel 92: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|MBH identificatie | | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"|MBH_920_chronisch-BSC | + | |style="background-color: white;"|MBH_920_mv_example-1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| |} | | |} |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_chronisch_VV-BSC | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_mv_example-1_VV |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="3" width="25%"| Gegevenselement | | |colspan="3" width="25%"| Gegevenselement |
Regel 869: |
Regel 102: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Identificatie | | |colspan="3"|Identificatie |
− | |style="background-color: white;"|MBH_920_chronisch_VV-BSC | + | |style="background-color: white;"|MBH_920_mv_example-1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Verstrekkingsverzoek datum | | |colspan="3"|Verstrekkingsverzoek datum |
Regel 879: |
Regel 112: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Zorgverlener | | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"|uuid_c776739b-e33e-11eb-2032-020000000000 | + | |style="background-color: white;"|Zie [[#UZI-000001111-PeterVanPulver|Zorgverlener: UZI-000001111-PeterVanPulver]] |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Te verstrekken hoeveelheid | | |colspan="3"|Te verstrekken hoeveelheid |
Regel 895: |
Regel 128: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Zorgaanbieder | | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"|uuid_c77673b5-e33e-11eb-2032-020000000000 | + | |style="background-color: white;"|Zie [[#URA-01236578-GulleGaper|Zorgaanbieder: URA-01236578-GulleGaper]] |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_chronisch_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_chronisch-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset1-MBH_920_chronisch-3 /><section end=mv-mvr-Scenarioset1-MBH_920_chronisch-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_chronisch==
| |
− | <section begin=mv-mvr-Scenarioset1-MBH_920_chronisch-4 /><section begin=patient-mv-mvr-Scenarioset1-MBH_920_chronisch-4 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset1-MBH_920_chronisch-4 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_920_chronisch-4 />
| |
− | ==== Scenario 1.4 - MBH_920_chronisch-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_chronisch_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_chronisch_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 30 dagen om 11:32 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 30 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7767373-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_chronisch-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_chronisch_VV_extraVVbestaandeMA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_chronisch_VV_extraVVbestaandeMA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 10 dagen om 11:35 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c77673be-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|90 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c77673d8-e33e-11eb-2032-020000000000
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Relatie medicatieafspraak | | |colspan="3"|Relatie medicatieafspraak |
Regel 1.033: |
Regel 134: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|MBH identificatie | | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"|MBH_920_chronisch-BSC | + | |style="background-color: white;"|MBH_920_mv_example-1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}<section end=mbhs-mv-mvr-Scenarioset1-MBH_920_chronisch-4 /><section end=mv-mvr-Scenarioset1-MBH_920_chronisch-4 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_dosis_stuks==
| |
− | <section begin=mv-mvr-Scenarioset1-MBH_920_dosis_stuks-6 /><section begin=patient-mv-mvr-Scenarioset1-MBH_920_dosis_stuks-6 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset1-MBH_920_dosis_stuks-6 /><section begin=mbhs-mv-mvr-Scenarioset1-MBH_920_dosis_stuks-6 />
| |
− | ==== Scenario 1.5 - MBH_920_dosis_stuks-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_dosis_stuks_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_dosis_stuks_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 130 dagen om 11:35 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 130 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 101 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7767567-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 dosis
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_dosis_stuks-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_dosis_stuks_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_dosis_stuks_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 130 dagen om 11:35 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c776758f-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c77675a9-e33e-11eb-2032-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_dosis_stuks_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_dosis_stuks-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset1-MBH_920_dosis_stuks-6 /><section end=mv-mvr-Scenarioset1-MBH_920_dosis_stuks-6 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_920_aanvullendeinstructie==
| |
− | <section begin=mv-mvr-Scenarioset2-MBH_920_aanvullendeinstructie-1 /><section begin=patient-mv-mvr-Scenarioset2-MBH_920_aanvullendeinstructie-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset2-MBH_920_aanvullendeinstructie-1 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_920_aanvullendeinstructie-1 />
| |
− | ==== Scenario 2.1 - MBH_920_aanvullendeinstructie-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 4 maanden om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 4 maanden
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 8 maanden
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c671b7-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_aanvullendeinstructie_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 4 maanden om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c671e0-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|180 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c671fa-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset2-MBH_920_aanvullendeinstructie-1 /><section end=mv-mvr-Scenarioset2-MBH_920_aanvullendeinstructie-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_920_toelichting==
| |
− | <section begin=mv-mvr-Scenarioset2-MBH_920_toelichting-2 /><section begin=patient-mv-mvr-Scenarioset2-MBH_920_toelichting-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset2-MBH_920_toelichting-2 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_920_toelichting-2 />
| |
− | ==== Scenario 2.2 - MBH_920_toelichting-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_toelichting_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 21 dagen om 08:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 21 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68e56-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toelichting
| |
− | |style="background-color: white;"|In overleg met specialist
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_toelichting_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 21 dagen om 08:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68e7f-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c68e99-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toelichting
| |
− | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset2-MBH_920_toelichting-2 /><section end=mv-mvr-Scenarioset2-MBH_920_toelichting-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_920_redenvanvoorschrijven==
| |
− | <section begin=mv-mvr-Scenarioset2-MBH_920_redenvanvoorschrijven-3 /><section begin=patient-mv-mvr-Scenarioset2-MBH_920_redenvanvoorschrijven-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset2-MBH_920_redenvanvoorschrijven-3 /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_920_redenvanvoorschrijven-3 />
| |
− | ==== Scenario 2.3 - MBH_920_redenvanvoorschrijven-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 13 dagen om 08:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 13 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 14 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68ed7-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Probleem naam
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per week 5 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_redenvanvoorschrijven_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 13 dagen om 08:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68f02-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|20 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c68f1c-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset2-MBH_920_redenvanvoorschrijven-3 /><section end=mv-mvr-Scenarioset2-MBH_920_redenvanvoorschrijven-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_920_aanvullendeinformatiewensen - MBH_920_Toedieningsweg==
| |
− | <section begin=mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensen /><section begin=patient-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensen />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensen /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensen />
| |
− | ==== Scenario 2.4 - MBH_920_aanvullendeinformatiewensen-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:06 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 4 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68f58-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende informatie
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_aanvullendeinformatiewensen_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 5 dagen om 08:06 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68f81-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c68f9b-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende wensen
| |
− | |style="background-color: white;"|3
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
| |
− | |}
| |
− | ==== Scenario 2.4 - MBH_920_Toedieningsweg-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_Toedieningsweg_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 2 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68fd9-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 druppel
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende informatie
| |
− | |style="background-color: white;"|3
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_Toedieningsweg_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 5 dagen om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c69003-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|1 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c6901d-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensen /><section end=mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensen />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_920_aanvullendeinformatiewensen==
| |
− | <section begin=mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensenLOS /><section begin=patient-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensenLOS />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensenLOS /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensenLOS />
| |
− | ==== Scenario 2.5 - MBH_920_aanvullendeinformatiewensen-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:06 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 4 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68f58-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende informatie
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_aanvullendeinformatiewensen_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 5 dagen om 08:06 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68f81-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c68f9b-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende wensen
| |
− | |style="background-color: white;"|3
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensenLOS /><section end=mv-mvr-Scenarioset2-MBH_920_aanvullendeinformatiewensenLOS />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 2 - MBH_920_Toedieningsweg==
| |
− | <section begin=mv-mvr-Scenarioset2-MBH_920_toedieningswegLOS /><section begin=patient-mv-mvr-Scenarioset2-MBH_920_toedieningswegLOS />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset2-MBH_920_toedieningswegLOS /><section begin=mbhs-mv-mvr-Scenarioset2-MBH_920_toedieningswegLOS />
| |
− | ==== Scenario 2.6 - MBH_920_Toedieningsweg-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_Toedieningsweg_MA-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg_MA-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 2 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c68fd9-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 1 druppel
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende informatie
| |
− | |style="background-color: white;"|3
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_Toedieningsweg_VV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg_VV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 5 dagen om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c7c69003-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|1 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c7c6901d-e33e-11eb-5258-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Toedieningsweg-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset2-MBH_920_toedieningswegLOS /><section end=mv-mvr-Scenarioset2-MBH_920_toedieningswegLOS />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_920_aanvullendeinstructie==
| |
− | <section begin=mv-mvr-Scenarioset3-MBH_920_aanvullendeinstructie-1 /><section begin=patient-mv-mvr-Scenarioset3-MBH_920_aanvullendeinstructie-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset3-MBH_920_aanvullendeinstructie-1 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_920_aanvullendeinstructie-1 />
| |
− | ==== Scenario 3.1 - MBH_920_aanvullendeinstructie-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA_staken-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA_staken-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 10 dagen om 18:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T - 10 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 4 maanden
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|2
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c80cc98a-e33e-11eb-3310-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T - 10 dagen, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset3-MBH_920_aanvullendeinstructie-1 /><section end=mv-mvr-Scenarioset3-MBH_920_aanvullendeinstructie-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_920_toelichting==
| |
− | <section begin=mv-mvr-Scenarioset3-MBH_920_toelichting-2 /><section begin=patient-mv-mvr-Scenarioset3-MBH_920_toelichting-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset3-MBH_920_toelichting-2 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_920_toelichting-2 />
| |
− | ==== Scenario 3.2 - MBH_920_toelichting-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_toelichting_MA_wijzigingmetVV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 2 dagen om 08:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 2 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c80ce5f9-e33e-11eb-3310-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 2 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_toelichting_MA_techstaken-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA_techstaken-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 2 dagen om 08:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 21 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 3 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|2
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c80ce627-e33e-11eb-3310-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting-VNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_toelichting_VV_extra-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting_VV_extra-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 2 dagen om 08:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c80ce64f-e33e-11eb-3310-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|60 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c80ce669-e33e-11eb-3310-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toelichting-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset3-MBH_920_toelichting-2 /><section end=mv-mvr-Scenarioset3-MBH_920_toelichting-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_920_redenvanvoorschrijven==
| |
− | <section begin=mv-mvr-Scenarioset3-MBH_920_redenvanvoorschrijven-3 /><section begin=patient-mv-mvr-Scenarioset3-MBH_920_redenvanvoorschrijven-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset3-MBH_920_redenvanvoorschrijven-3 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_920_redenvanvoorschrijven-3 />
| |
− | ==== Scenario 3.3 - MBH_920_redenvanvoorschrijven-VNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 1 dag om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 14 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c80ce6c2-e33e-11eb-3310-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Probleem naam
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 4 stuks, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per week 4 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
| |
| |} | | |} |
| + | ==== Bouwstenen ==== |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_techstaken-VNK | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Bouwstenen |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |colspan="3" width="25%"| Gegevenselement | + | |colspan="5" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
| | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 1 dag om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 13 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 2 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Voorschrijver | + | |colspan="6"|<span id="UZI-000001111-PeterVanPulver" title="Intern ID = UZI-000001111-PeterVanPulver">Zorgverlener met id: UZI-000001111-PeterVanPulver</span> |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="2"|Zorgverlener | + | |rowspan="12"| |
− | |style="background-color: white;"|uuid_c80ce6f3-e33e-11eb-3310-020000000000
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Probleem naam | + | |colspan="4"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Geneesmiddel - primaire code | + | |colspan="4"|Naamgegevens |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | + | |style="background-color: white;"|Peter van Pulver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Geneesmiddel - generiekere code | + | |colspan="4"|Specialisme |
− | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruiksinstructie | + | |colspan="5"|Contactgegevens |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="4"| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 1 maal per week 5 stuks, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per week 5 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset3-MBH_920_redenvanvoorschrijven-3 /><section end=mv-mvr-Scenarioset3-MBH_920_redenvanvoorschrijven-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 3 (Staken Wijzigen) - MBH_920_aanvullendeinformatiewensen==
| |
− | <section begin=mv-mvr-Scenarioset3-MBH_920_aanvullendeinformatiewensen-4 /><section begin=patient-mv-mvr-Scenarioset3-MBH_920_aanvullendeinformatiewensen-4 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|C.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Vonker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910401 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-02-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset3-MBH_920_aanvullendeinformatiewensen-4 /><section begin=mbhs-mv-mvr-Scenarioset3-MBH_920_aanvullendeinformatiewensen-4 />
| |
− | ==== Scenario 3.4 - MBH_920_aanvullendeinformatiewensen-VNK====
| |
− |
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 1 dag om 18:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 4 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Voorschrijver | + | |colspan="4"|Telefoonnummers |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="2"| | | |rowspan="2"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="2"|Zorgverlener | + | |colspan="2"|Telefoonnummer |
− | |style="background-color: white;"|uuid_c80ce761-e33e-11eb-3310-020000000000 | + | |style="background-color: white;"|0101234567 |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aanvullende informatie
| |
− | |style="background-color: white;"|1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Relatie medicatieafspraak | + | |colspan="5"|Zorgaanbieder |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset3-MBH_920_aanvullendeinformatiewensen-4 /><section end=mv-mvr-Scenarioset3-MBH_920_aanvullendeinformatiewensen-4 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 4 (Lengte Gewicht) - MBH_920_Lengte_Gewicht==
| |
− | <section begin=mv-mvr-Scenarioset4_a-MBH_920_Lengte_Gewicht-1 /><section begin=patient-mv-mvr-Scenarioset4_a-MBH_920_Lengte_Gewicht-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Molenaars
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910449 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset4_a-MBH_920_Lengte_Gewicht-1 /><section begin=mbhs-mv-mvr-Scenarioset4_a-MBH_920_Lengte_Gewicht-1 />
| |
− | ==== Scenario 4.1 - MBH_920_Lengte_Gewicht-MLN====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_Lengte_Gewicht_MA_1-MLN
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1-MLN
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 1 jaar om 07:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 1 jaar
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c851e8d6-e33e-11eb-2642-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht-MLN
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_Lengte_Gewicht_VV_1-MLN
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht_VV_1-MLN
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 1 jaar om 07:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c8520559-e33e-11eb-2642-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|180 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c8520573-e33e-11eb-2642-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht-MLN
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset4_a-MBH_920_Lengte_Gewicht-1 /><section end=mv-mvr-Scenarioset4_a-MBH_920_Lengte_Gewicht-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 4 (Lengte Gewicht) - MBH_920_Lengte_Gewicht==
| |
− | <section begin=mv-mvr-Scenarioset4_b-MBH_920_Lengte_Gewicht-persistent-1 /><section begin=patient-mv-mvr-Scenarioset4_b-MBH_920_Lengte_Gewicht-persistent-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Molenaars
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910449 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset4_b-MBH_920_Lengte_Gewicht-persistent-1 /><section begin=mbhs-mv-mvr-Scenarioset4_b-MBH_920_Lengte_Gewicht-persistent-1 />
| |
− | ==== Scenario 4.1 - MBH_920_Lengte_Gewicht-MLN====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_Lengte_Gewicht_MA_1-MLN
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1-MLN
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 1 jaar om 07:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 jaar''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 1 jaar
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c851e8d6-e33e-11eb-2642-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 1 jaar, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht-MLN
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_Lengte_Gewicht_VV_1-MLN
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht_VV_1-MLN
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 1 jaar om 07:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c8520559-e33e-11eb-2642-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|180 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLETMSR 100MG (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c8520573-e33e-11eb-2642-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_Lengte_Gewicht-MLN
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset4_b-MBH_920_Lengte_Gewicht-persistent-1 /><section end=mv-mvr-Scenarioset4_b-MBH_920_Lengte_Gewicht-persistent-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_variabelefrequentie==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_variabelefrequentie-1 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_variabelefrequentie-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_variabelefrequentie-1 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelefrequentie-1 />
| |
− | ==== Scenario 6.1 - MBH_920_variabelefrequentie-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_variabelefrequentie_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelefrequentie_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 16 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbe07-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelefrequentie-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_variabelefrequentie_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelefrequentie_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbe30-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|90 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cbe4a-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_variabelefrequentie_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelefrequentie-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelefrequentie-1 /><section end=mv-mvr-Scenarioset6-MBH_920_variabelefrequentie-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_interval==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_interval-2 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_interval-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_interval-2 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_interval-2 />
| |
− | ==== Scenario 6.2 - MBH_920_interval-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_interval_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_interval_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:04 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdaa6-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, exact iedere 8 uur 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|exact iedere 8 uur 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_interval-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_interval_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_interval_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:04 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdacb-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|90 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cdae5-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_interval_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_interval-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_interval-2 /><section end=mv-mvr-Scenarioset6-MBH_920_interval-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_variabelehoeveelheid==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid-3 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid-3 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid-3 />
| |
− | ==== Scenario 6.3 - MBH_920_variabelehoeveelheid-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheid_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 28 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdb1d-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag stuks, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_variabelehoeveelheid_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdb46-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|100 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cdb60-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid-3 /><section end=mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_zonderkeerdosis==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_zonderkeerdosis-4 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_zonderkeerdosis-4 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_zonderkeerdosis-4 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_zonderkeerdosis-4 />
| |
− | ==== Scenario 6.4 - MBH_920_zonderkeerdosis-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_zonderkeerdosis_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_zonderkeerdosis_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 28 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdb9d-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_zonderkeerdosis-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_zonderkeerdosis_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_zonderkeerdosis_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:12 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdbc2-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cdbdc-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_zonderkeerdosis_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_zonderkeerdosis-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_zonderkeerdosis-4 /><section end=mv-mvr-Scenarioset6-MBH_920_zonderkeerdosis-4 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_bijzonderekeerdosis==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_bijzonderekeerdosis-5 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_bijzonderekeerdosis-5 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_bijzonderekeerdosis-5 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_bijzonderekeerdosis-5 />
| |
− | ==== Scenario 6.5 - MBH_920_bijzonderekeerdosis-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_bijzonderekeerdosis_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 28 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdc15-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag 0.5 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_bijzonderekeerdosis-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_bijzonderekeerdosis_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:15 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdc3d-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cdc57-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_bijzonderekeerdosis-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_bijzonderekeerdosis-5 /><section end=mv-mvr-Scenarioset6-MBH_920_bijzonderekeerdosis-5 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_variabelehoeveelheid2==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid2-6 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid2-6 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid2-6 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid2-6 />
| |
− | ==== Scenario 6.6 - MBH_920_variabelehoeveelheid2-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheid2_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:18 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 28 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdc93-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|2 maal per dag ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid2-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_variabelehoeveelheid2_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:18 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdcbe-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|450 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cdcd8-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheid2-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid2-6 /><section end=mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheid2-6 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_tijdstippen==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_tijdstippen-7 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_tijdstippen-7 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_tijdstippen-7 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_tijdstippen-7 />
| |
− | ==== Scenario 6.7 - MBH_920_tijdstippen-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_tijdstippen_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_tijdstippen_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:24 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 14 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdd17-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_tijdstippen-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_tijdstippen_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_tijdstippen_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:24 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdd3e-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|42 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cdd58-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_tijdstippen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_tijdstippen-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_tijdstippen-7 /><section end=mv-mvr-Scenarioset6-MBH_920_tijdstippen-7 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_weekdagen==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_weekdagen-8 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_weekdagen-8 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_weekdagen-8 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_weekdagen-8 />
| |
− | ==== Scenario 6.8 - MBH_920_weekdagen-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_weekdagen_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_weekdagen_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:25 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 70 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cdd93-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Aanvullende instructie
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|op maandag, woensdag en vrijdag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_weekdagen-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_weekdagen_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_weekdagen_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:25 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cddb8-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cddd2-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_weekdagen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_weekdagen-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_weekdagen-8 /><section end=mv-mvr-Scenarioset6-MBH_920_weekdagen-8 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_dagdeel==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_dagdeel-9 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_dagdeel-9 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_dagdeel-9 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_dagdeel-9 />
| |
− | ==== Scenario 6.9 - MBH_920_dagdeel-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_dagdeel_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_dagdeel_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:27 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbeca-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 stuk 's avonds
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_dagdeel-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_dagdeel_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_dagdeel_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:27 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbeef-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|60 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cbf09-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_dagdeel_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_dagdeel-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_dagdeel-9 /><section end=mv-mvr-Scenarioset6-MBH_920_dagdeel-9 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_cyclischschema==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_cyclischschema-10 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_cyclischschema-10 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_cyclischschema-10 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_cyclischschema-10 />
| |
− | ==== Scenario 6.10 - MBH_920_cyclischschema-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_cyclischschema_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_cyclischschema_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:33 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbf40-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Herhaalperiode cyclisch schema
| |
− | |style="background-color: white;"|28
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_cyclischschema-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_cyclischschema_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_cyclischschema_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:33 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbf6a-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|126 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cbf84-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_cyclischschema_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_cyclischschema-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_cyclischschema-10 /><section end=mv-mvr-Scenarioset6-MBH_920_cyclischschema-10 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_afbouwschema==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_afbouwschema-11 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_afbouwschema-11 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_afbouwschema-11 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_afbouwschema-11 />
| |
− | ==== Scenario 6.11 - MBH_920_afbouwschema-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_afbouwschema_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_afbouwschema_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:40 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 41 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cbfc2-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie 1
| |
− | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie 2
| |
− | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie 3
| |
− | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_afbouwschema-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_afbouwschema_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_afbouwschema_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:40 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc006-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|90 gram
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cc020-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_afbouwschema_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_afbouwschema-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_afbouwschema-11 /><section end=mv-mvr-Scenarioset6-MBH_920_afbouwschema-11 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_variabelehoeveelheidenmaximum==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheidenmaximum-12 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheidenmaximum-12 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheidenmaximum-12 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheidenmaximum-12 />
| |
− | ==== Scenario 6.12 - MBH_920_variabelehoeveelheidenmaximum-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheidenmaximum_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:45 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 21 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc078-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, bij hoest stuks , maximaal 6 stuks per dag, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|bij hoest stuks , maximaal 6 stuks per dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_variabelehoeveelheidenmaximum_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:45 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc0a3-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|120 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cc0bd-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheidenmaximum-12 /><section end=mv-mvr-Scenarioset6-MBH_920_variabelehoeveelheidenmaximum-12 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_toedieningssnelheid==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_toedieningssnelheid-13 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_toedieningssnelheid-13 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_toedieningssnelheid-13 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_toedieningssnelheid-13 />
| |
− | ==== Scenario 6.13 - MBH_920_toedieningssnelheid-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_toedieningssnelheid_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:47 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 8 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc0fc-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: ml per uur, parenteraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|toedieningssnelheid: ml per uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningssnelheid-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_toedieningssnelheid_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningssnelheid_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:47 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc121-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|100 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cc13b-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_toedieningssnelheid_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningssnelheid-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_toedieningssnelheid-13 /><section end=mv-mvr-Scenarioset6-MBH_920_toedieningssnelheid-13 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_toedieningsduur==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_toedieningsduur-14 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_toedieningsduur-14 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_toedieningsduur-14 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_toedieningsduur-14 />
| |
− | ==== Scenario 6.14 - MBH_920_toedieningsduur-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_toedieningsduur_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningsduur_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:49 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc173-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, transdermaal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningsduur-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_toedieningsduur_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningsduur_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:49 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc19c-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cc1b6-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_toedieningsduur_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_toedieningsduur-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_toedieningsduur-14 /><section end=mv-mvr-Scenarioset6-MBH_920_toedieningsduur-14 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 6 (Doseerschemas) - MBH_920_zonodig==
| |
− | <section begin=mv-mvr-Scenarioset6-MBH_920_zonodig-15 /><section begin=patient-mv-mvr-Scenarioset6-MBH_920_zonodig-15 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset6-MBH_920_zonodig-15 /><section begin=mbhs-mv-mvr-Scenarioset6-MBH_920_zonodig-15 />
| |
− | ==== Scenario 6.15 - MBH_920_zonodig-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_zonodig_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_zonodig_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 08:57 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 27 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc1f2-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, zo nodig 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_zonodig-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_zonodig_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_zonodig_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 08:57 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c93cc21d-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|14 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c93cc237-e33e-11eb-3662-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_zonodig_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_zonodig-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset6-MBH_920_zonodig-15 /><section end=mv-mvr-Scenarioset6-MBH_920_zonodig-15 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 7 (Magistraal) - MBH_920_magistraalalleingredienten==
| |
− | <section begin=mv-mvr-Scenarioset7-MBH_920_magistraalalleingredienten-1 /><section begin=patient-mv-mvr-Scenarioset7-MBH_920_magistraalalleingredienten-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset7-MBH_920_magistraalalleingredienten-1 /><section begin=mbhs-mv-mvr-Scenarioset7-MBH_920_magistraalalleingredienten-1 />
| |
− | ==== Scenario 7.1 - MBH_920_magistraalalleingredienten-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_magistraalalleingredienten_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 12:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Einddatum
| |
− | |style="background-color: white;"|T + 31 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9a89f37-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="11"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, zo nodig, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|zo nodig
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalalleingredienten-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_magistraalalleingredienten_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalalleingredienten_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 12:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9a89f6d-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|100 ml
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="11"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Beoogd verstrekker
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="2"| | | |rowspan="2"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Zorgaanbieder | | |colspan="3"|Zorgaanbieder |
− | |style="background-color: white;"|uuid_c9a8bbbb-e33e-11eb-1255-020000000000 | + | |style="background-color: white;"|Zie [[#URA-00001111-PulverPartners|Zorgaanbieder: URA-00001111-PulverPartners]] |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_magistraalalleingredienten_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalalleingredienten-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset7-MBH_920_magistraalalleingredienten-1 /><section end=mv-mvr-Scenarioset7-MBH_920_magistraalalleingredienten-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 7 (Magistraal) - MBH_920_magistraalactieveingredient==
| |
− | <section begin=mv-mvr-Scenarioset7-MBH_920_magistraalactieveingredient-2 /><section begin=patient-mv-mvr-Scenarioset7-MBH_920_magistraalactieveingredient-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset7-MBH_920_magistraalactieveingredient-2 /><section begin=mbhs-mv-mvr-Scenarioset7-MBH_920_magistraalactieveingredient-2 />
| |
− | ==== Scenario 7.2 - MBH_920_magistraalactieveingredient-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_magistraalactieveingredient_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 12:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Ingangsdatum
| |
− | |style="background-color: white;"|T + 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Einddatum
| |
− | |style="background-color: white;"|T + 70 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9a8bc17-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalactieveingredient-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_magistraalactieveingredient_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalactieveingredient_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 12:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9a8bc46-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|100 gram
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9a8bc6b-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_magistraalactieveingredient_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraalactieveingredient-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset7-MBH_920_magistraalactieveingredient-2 /><section end=mv-mvr-Scenarioset7-MBH_920_magistraalactieveingredient-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 7 (Magistraal) - MBH_920_magistraal90miljoennr==
| |
− | <section begin=mv-mvr-Scenarioset7-MBH_920_magistraal90miljoennr-3 /><section begin=patient-mv-mvr-Scenarioset7-MBH_920_magistraal90miljoennr-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|S.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Jankie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910437 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-05-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|3
| |
− | |}<section end=patient-mv-mvr-Scenarioset7-MBH_920_magistraal90miljoennr-3 /><section begin=mbhs-mv-mvr-Scenarioset7-MBH_920_magistraal90miljoennr-3 />
| |
− | ==== Scenario 7.3 - MBH_920_magistraal90miljoennr-JNK====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_920_magistraal90miljoennr_MA-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MA-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 12:08 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Einddatum
| |
− | |style="background-color: white;"|T + 30 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9a8bcb7-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="8"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraal90miljoennr-JNK
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_920_magistraal90miljoennr_VV-JNK
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraal90miljoennr_VV-JNK
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 12:08 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9a8bce6-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|100 gram
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="8"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Ingredient
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingredient code
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Sterkte
| |
− | |style="background-color: white;"| per
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9a8bd0b-e33e-11eb-1255-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_magistraal90miljoennr_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_magistraal90miljoennr-JNK
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset7-MBH_920_magistraal90miljoennr-3 /><section end=mv-mvr-Scenarioset7-MBH_920_magistraal90miljoennr-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_VVandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset8-MBH_920_VVandermansMA-1 /><section begin=patient-mv-mvr-Scenarioset8-MBH_920_VVandermansMA-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset8-MBH_920_VVandermansMA-1 /><section begin=mbhs-mv-mvr-Scenarioset8-MBH_920_VVandermansMA-1 />
| |
− | ==== Scenario 8.1 - MBH_920_VVandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_VVandermansMA_MA-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 14 dagen om 09:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 14 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 6 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f22b58-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruiksinstructie | + | |colspan="6"|<span id="URA-00001111-PulverPartners" title="Intern ID = URA-00001111-PulverPartners">Zorgaanbieder met id: URA-00001111-PulverPartners</span> |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="4"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="2"|Omschrijving | + | |colspan="4"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Kopie indicator
| |
− | |style="background-color: white;"|true
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA-ZTP
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_VVandermansMA_VV-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA_VV-ZTP | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 09:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f22b80-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|6 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9f22b9a-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset8-MBH_920_VVandermansMA-1 /><section end=mv-mvr-Scenarioset8-MBH_920_VVandermansMA-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_VVandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset08-MBH_920_VVandermansMA /><section begin=patient-mv-mvr-Scenarioset08-MBH_920_VVandermansMA />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset08-MBH_920_VVandermansMA /><section begin=mbhs-mv-mvr-Scenarioset08-MBH_920_VVandermansMA />
| |
− | ==== Scenario 8i.01 - MBH_920_VVandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_VVandermansMA_MA-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Identificatie | + | |colspan="4"|Organisatie naam |
− | |style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Medicatieafspraak datum tijd | + | |colspan="4"|Adresgegevens |
− | |style="background-color: white;"|T - 14 dagen om 09:00 uur | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Gebruiksperiode | + | |colspan="6"|<span id="URA-01236578-GulleGaper" title="Intern ID = URA-01236578-GulleGaper">Zorgaanbieder met id: URA-01236578-GulleGaper</span> |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 6 dagen''
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="3"| | | |rowspan="3"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="2"|Ingangsdatum
| + | |colspan="4"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"|T - 14 dagen
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 6 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f22b58-e33e-11eb-1986-020000000000 | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 14 dagen, tot en met T + 6 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA-ZTP
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_VVandermansMA_andermansVV-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 14 dagen om 09:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f22ba3-e33e-11eb-1986-020000000000
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Te verstrekken hoeveelheid
| + | |colspan="4"|Organisatie naam |
− | |style="background-color: white;"|21 stuks
| + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| + | |}<section end=mbhs-mv-example-920-1 /><section end=mv-example-920-1 /> |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9f247dd-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_VVandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset08-MBH_920_VVandermansMA /><section end=mv-mvr-Scenarioset08-MBH_920_VVandermansMA />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_stakenandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset8-MBH_920_stakenandermansMA-2 /><section begin=patient-mv-mvr-Scenarioset8-MBH_920_stakenandermansMA-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset8-MBH_920_stakenandermansMA-2 /><section begin=mbhs-mv-mvr-Scenarioset8-MBH_920_stakenandermansMA-2 />
| |
− | ==== Scenario 8.2 - MBH_920_stakenandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_stakenandermansMA_MA2-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA_MA2-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 09:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|2
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f2482d-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset8-MBH_920_stakenandermansMA-2 /><section end=mv-mvr-Scenarioset8-MBH_920_stakenandermansMA-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_stakenandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset08-MBH_920_stakenandermansMA /><section begin=patient-mv-mvr-Scenarioset08-MBH_920_stakenandermansMA />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset08-MBH_920_stakenandermansMA /><section begin=mbhs-mv-mvr-Scenarioset08-MBH_920_stakenandermansMA />
| |
− | ==== Scenario 8i.02 - MBH_920_stakenandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_stakenandermansMA_MA1-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 5 dagen om 08:45 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 15 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 5 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 15 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f24858-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 15 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA-ZTP
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_stakenandermansMA_andermansVV-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 5 dagen om 08:45 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f24880-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|21 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9f2489a-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_stakenandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset08-MBH_920_stakenandermansMA /><section end=mv-mvr-Scenarioset08-MBH_920_stakenandermansMA />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_onderbrekenandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset8-MBH_920_onderbrekenandermansMA-3 /><section begin=patient-mv-mvr-Scenarioset8-MBH_920_onderbrekenandermansMA-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset8-MBH_920_onderbrekenandermansMA-3 /><section begin=mbhs-mv-mvr-Scenarioset8-MBH_920_onderbrekenandermansMA-3 />
| |
− | ==== Scenario 8.3 - MBH_920_onderbrekenandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_onderbrekenandermansMA_MA2-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA2-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 09:07 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 60 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f248f8-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset8-MBH_920_onderbrekenandermansMA-3 /><section end=mv-mvr-Scenarioset8-MBH_920_onderbrekenandermansMA-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_onderbrekenandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset08-MBH_920_onderbrekenandermansMA /><section begin=patient-mv-mvr-Scenarioset08-MBH_920_onderbrekenandermansMA />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset08-MBH_920_onderbrekenandermansMA /><section begin=mbhs-mv-mvr-Scenarioset08-MBH_920_onderbrekenandermansMA />
| |
− | ==== Scenario 8i.03 - MBH_920_onderbrekenandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_onderbrekenandermansMA_MA1-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 60 dagen om 09:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 29 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 60 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 29 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f24923-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 29 dagen, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_onderbrekenandermansMA_andermansVV-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 60 dagen om 09:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f2494b-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|90 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9f24965-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset08-MBH_920_onderbrekenandermansMA /><section end=mv-mvr-Scenarioset08-MBH_920_onderbrekenandermansMA />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_wijzigenandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset8-MBH_920_wijzigenandermansMA-4 /><section begin=patient-mv-mvr-Scenarioset8-MBH_920_wijzigenandermansMA-4 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset8-MBH_920_wijzigenandermansMA-4 /><section begin=mbhs-mv-mvr-Scenarioset8-MBH_920_wijzigenandermansMA-4 />
| |
− | ==== Scenario 8.4 - MBH_920_wijzigenandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA_techstaken-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA_techstaken-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 09:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 7 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak stop type
| |
− | |style="background-color: white;"|2
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f249c3-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 1 maal per dag 2 stuks, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 2 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA2-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA2-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 09:10 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f249ee-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Reden wijzigen of staken
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Relatie medicatieafspraak
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset8-MBH_920_wijzigenandermansMA-4 /><section end=mv-mvr-Scenarioset8-MBH_920_wijzigenandermansMA-4 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 8 (andermans MA) - MBH_920_wijzigenandermansMA==
| |
− | <section begin=mv-mvr-Scenarioset08-MBH_920_wijzigenandermansMA /><section begin=patient-mv-mvr-Scenarioset08-MBH_920_wijzigenandermansMA />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|H.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Zutphen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999910498 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1954-06-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset08-MBH_920_wijzigenandermansMA /><section begin=mbhs-mv-mvr-Scenarioset08-MBH_920_wijzigenandermansMA />
| |
− | ==== Scenario 8i.04 - MBH_920_wijzigenandermansMA-ZTP====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA1-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 7 dagen om 07:50 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T + 13 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 7 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 13 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f24a19-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 7 dagen, tot en met T + 13 dagen, 1 maal per dag 2 stuks, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 2 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_wijzigenandermansMA_andermansVV-ZTP
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_andermansVV-ZTP
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 7 dagen om 07:50 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_c9f24a41-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|42 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_c9f24a5b-e33e-11eb-1986-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset08-MBH_920_wijzigenandermansMA /><section end=mv-mvr-Scenarioset08-MBH_920_wijzigenandermansMA />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 9 (diversen VV) - MBH_920_logistiekeverbruiksperiode_start_eind==
| |
− | <section begin=mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_start_eind-1 /><section begin=patient-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_start_eind-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_start_eind-1 /><section begin=mbhs-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_start_eind-1 />
| |
− | ==== Scenario 9.1a - MBH_920_logistiekeverbruiksperiode_start_eind-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_start_eind_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 11:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen, tot en met T + 12 maanden''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T + 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 12 maanden
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50c618-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 12 maanden, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_start_eind_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 11:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e28a-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aantal herhalingen
| |
− | |style="background-color: white;"|3
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verbruiksperiode
| |
− | |style="background-color: white;"|Vanaf T + 10 dagen, tot en met T + 6 maanden
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_ca50e2a5-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_start_eind-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_start_eind-1 /><section end=mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_start_eind-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 9 (diversen VV) - MBH_920_logistiekeverbruiksperiode_eind==
| |
− | <section begin=mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_eind-4 /><section begin=patient-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_eind-4 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_eind-4 /><section begin=mbhs-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_eind-4 /> | |
− | ==== Scenario 9.1b - MBH_920_logistiekeverbruiksperiode_eind-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_eind_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 9 dagen om 11:01 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 200 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 9 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 200 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e3fc-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 9 dagen, tot en met T + 200 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_eind_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 9 dagen om 11:01 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e424-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verbruiksperiode
| |
− | |style="background-color: white;"|tot en met T + 200 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_ca50e43d-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_eind-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_eind-4 /><section end=mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_eind-4 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 9 (diversen VV) - MBH_920_logistiekeverbruiksperiode_duur_dagen==
| |
− | <section begin=mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_duur_dagen-5 /><section begin=patient-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_duur_dagen-5 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_duur_dagen-5 /><section begin=mbhs-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_duur_dagen-5 />
| |
− | ==== Scenario 9.1c - MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_logistiekeverbruiksperiode_duur_dagen_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 11:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 150 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e479-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_logistiekeverbruiksperiode_duur_dagen_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 11:02 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e4a1-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verbruiksperiode
| |
− | |style="background-color: white;"|gedurende 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_ca50e4ba-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_logistiekeverbruiksperiode_duur_dagen-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_duur_dagen-5 /><section end=mv-mvr-Scenarioset9-MBH_920_logistiekeverbruiksperiode_duur_dagen-5 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 9 (diversen VV) - MBH_920_herhalingen==
| |
− | <section begin=mv-mvr-Scenarioset9-MBH_920_herhalingen-2 /><section begin=patient-mv-mvr-Scenarioset9-MBH_920_herhalingen-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset9-MBH_920_herhalingen-2 /><section begin=mbhs-mv-mvr-Scenarioset9-MBH_920_herhalingen-2 />
| |
− | ==== Scenario 9.2 - MBH_920_herhalingen-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_herhalingen_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_herhalingen_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 50 dagen om 11:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 50 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e2fe-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 50 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_herhalingen-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_herhalingen_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_herhalingen_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 50 dagen om 11:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e326-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Aantal herhalingen
| |
− | |style="background-color: white;"|5
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_ca50e341-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_herhalingen_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_herhalingen-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset9-MBH_920_herhalingen-2 /><section end=mv-mvr-Scenarioset9-MBH_920_herhalingen-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 9 (diversen VV) - MBH_920_afleverlocatie==
| |
− | <section begin=mv-mvr-Scenarioset9-MBH_920_afleverlocatie-3 /><section begin=patient-mv-mvr-Scenarioset9-MBH_920_afleverlocatie-3 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset9-MBH_920_afleverlocatie-3 /><section begin=mbhs-mv-mvr-Scenarioset9-MBH_920_afleverlocatie-3 />
| |
− | ==== Scenario 9.3 - MBH_920_afleverlocatie-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_afleverlocatie_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_afleverlocatie_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 11:07 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 10 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T + 1 dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 10 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e37c-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 10 dagen, 3 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|3 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_afleverlocatie-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_afleverlocatie_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_afleverlocatie_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 11:07 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_ca50e3a4-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|30 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_ca50e3be-e33e-11eb-7948-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Afleverlocatie
| |
− | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_afleverlocatie_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_afleverlocatie-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset9-MBH_920_afleverlocatie-3 /><section end=mv-mvr-Scenarioset9-MBH_920_afleverlocatie-3 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 10 (HPKZI) - MBH_920_HPKvoorschrijven==
| |
− | <section begin=mv-mvr-Scenarioset10-MBH_920_HPKvoorschrijven-1 /><section begin=patient-mv-mvr-Scenarioset10-MBH_920_HPKvoorschrijven-1 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset10-MBH_920_HPKvoorschrijven-1 /><section begin=mbhs-mv-mvr-Scenarioset10-MBH_920_HPKvoorschrijven-1 />
| |
− | ==== Scenario 10.1 - MBH_920_HPKvoorschrijven-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_HPKvoorschrijven_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 170 dagen om 13:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 170 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T - 21 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_caa06cb8-e33e-11eb-2077-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_HPKvoorschrijven-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_HPKvoorschrijven_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_HPKvoorschrijven_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 170 dagen om 13:00 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_caa06ce1-e33e-11eb-2077-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|150 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_caa06cfc-e33e-11eb-2077-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_HPKvoorschrijven_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_HPKvoorschrijven-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset10-MBH_920_HPKvoorschrijven-1 /><section end=mv-mvr-Scenarioset10-MBH_920_HPKvoorschrijven-1 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 10 (HPKZI) - MBH_920_ZINRvoorschrijven==
| |
− | <section begin=mv-mvr-Scenarioset10-MBH_920_ZINRvoorschrijven-2 /><section begin=patient-mv-mvr-Scenarioset10-MBH_920_ZINRvoorschrijven-2 />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-mvr-Scenarioset10-MBH_920_ZINRvoorschrijven-2 /><section begin=mbhs-mv-mvr-Scenarioset10-MBH_920_ZINRvoorschrijven-2 />
| |
− | ==== Scenario 10.2 - MBH_920_ZINRvoorschrijven-BSC====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_ZINRvoorschrijven_MA-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T om 13:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Einddatum
| |
− | |style="background-color: white;"|T + 150 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_caa08958-e33e-11eb-2077-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|INDAPAMIDE SANDOZ TABLET 2,5MG (code = '14896087' in codeSystem 'G-Standaard ZI-nr')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INDAPAMIDE SANDOZ TABLET 2,5MG (code = '685410' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven-BSC
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_ZINRvoorschrijven_VV-BSC
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_VV-BSC
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T om 13:05 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|uuid_caa08982-e33e-11eb-2077-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|150 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|INDAPAMIDE SANDOZ TABLET 2,5MG (code = '14896087' in codeSystem 'G-Standaard ZI-nr')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INDAPAMIDE SANDOZ TABLET 2,5MG (code = '685410' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|uuid_caa0899e-e33e-11eb-2077-020000000000
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_ZINRvoorschrijven-BSC
| |
− | |}<section end=mbhs-mv-mvr-Scenarioset10-MBH_920_ZINRvoorschrijven-2 /><section end=mv-mvr-Scenarioset10-MBH_920_ZINRvoorschrijven-2 />
| |
− | == MP KWALIFICATIE Medicatievoorschriften Scenarioset 1 - MBH_920_chronisch==
| |
− | <section begin=mv-Test1-arianne-finindcode /><section begin=patient-mv-Test1-arianne-finindcode />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Naamgegevens
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="7"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Initialen
| |
− | |style="background-color: white;"|A.
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Naamgebruik
| |
− | |style="background-color: white;"|1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslachtsnaam
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Voorvoegsels
| |
− | |style="background-color: white;"|van de
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Achternaam
| |
− | |style="background-color: white;"|XXX_Boschman
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatienummer
| |
− | |style="background-color: white;"|999912100 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geboortedatum
| |
− | |style="background-color: white;"|1964-01-08
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geslacht
| |
− | |style="background-color: white;"|2
| |
− | |}<section end=patient-mv-Test1-arianne-finindcode /><section begin=mbhs-mv-Test1-arianne-finindcode />
| |
− | ==== Scenario 999 - MBH_920_test1-AWE====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_920_test1-AWE-MA
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_test1-AWE-MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Medicatieafspraak datum tijd
| |
− | |style="background-color: white;"|T - 30 dagen om 11:32 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Gebruiksperiode
| |
− | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Ingangsdatum
| |
− | |style="background-color: white;"|T - 30 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|UZI-000001111-PeterVanPulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, Oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Toedieningsweg
| |
− | |style="background-color: white;"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_test1-AWE
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_920_test1-AWE_VV
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="3" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatie
| |
− | |style="background-color: white;"|MBH_920_test1-AWE_VV
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Verstrekkingsverzoek datum
| |
− | |style="background-color: white;"|T - 30 dagen om 11:32 uur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgverlener
| |
− | |style="background-color: white;"|UZI-000001111-PeterVanPulver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Te verstrekken hoeveelheid
| |
− | |style="background-color: white;"|21 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Beoogd verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Zorgaanbieder
| |
− | |style="background-color: white;"|URA-01236578-GulleGaper
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Relatie medicatieafspraak
| |
− | |style="background-color: white;"|MBH_920_chronisch_MA
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_920_test1-AWE
| |
− | |}<section end=mbhs-mv-Test1-arianne-finindcode /><section end=mv-Test1-arianne-finindcode />
| |
| | | |
| [[Categorie:Kwalificatie]] | | [[Categorie:Kwalificatie]] |